Ohio NAELA News

Welcome to the news blog of the National Academy of Elder Law Attorneys Ohio Chapter. Here we share news related to Elder Law, Estate Planning, Probate and Special Needs Planning, Veterans Benefits and more — for the benefit of our Chapter members, and the general public seeking more information about Elder Law.

10 prescription drugs Medicare will negotiate first

10 prescription drugs Medicare will negotiate first

From AARP.org — By Dena Bunis —   The names of the first 10 Medicare drugs whose prices the federal government will negotiate directly with manufacturers were released today, Aug. 29. It marks the first time in history that the price of life-sustaining medications...

After Dayton man’s partner died, Ohio Medicaid came after his house

After Dayton man’s partner died, Ohio Medicaid came after his house

From The Dayton Daily News — By Nick Blizzard —   Joseph Applegate fought the Medicaid estate recovery letter he received from Ohio seeking to collect his home. He stopped the process, but nine years later the lien on his house remains. The Dayton man said he was...

Battle brewing over Biden’s nursing home staffing requirements

Battle brewing over Biden’s nursing home staffing requirements

From The Hill — By Nathaniel Weixel —   A major fight is brewing between the Biden administration and the powerful nursing home industry over a proposed minimum staffing requirement for the nation’s 15,500 nursing homes. President Biden last year announced a slate of...

Help seniors adjust to new living environments

Help seniors adjust to new living environments

Tips for transitioning to an assisted living facility From the USA Today Network via The Columbus Dispatch — By Lisa Conway —  Settling into a new environment requires a period of adjustment. Learning the physical aspects of a location, making new friends and adapting...

FDA approves anti-Alzheimer’s drug Leqembi. What you need to know

FDA approves anti-Alzheimer’s drug Leqembi. What you need to know

From Forbes —  By Howard Gleckman —   The Food and Drug Administration’s decision to grant accelerated approval for the anti-Alzheimer’s drug lecanemab, which will be sold as Leqembi, has significant potential for research into treatment of the disease. But people...

Learn more about Ohio NAELA